Edition:
United Kingdom

Fibrocell Science Inc (FCSC.OQ)

FCSC.OQ on NASDAQ Stock Exchange Capital Market

2.01USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,052
52-wk High
$14.55
52-wk Low
$1.75

Chart for

About

Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $43.12
Shares Outstanding(Mil.): 14.72
Dividend: --
Yield (%): --

Financials

  FCSC.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -1.69 -- --
ROI: -226.40 0.45 14.28
ROE: -2,073.35 1.37 16.00

BRIEF-Fibrocell Reports Q1 Loss Per Share $0.11

* FIBROCELL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

10 May 2018

Earnings vs. Estimates